MS in the Media
This is an archive of news and feature stories from the internet that may be of interest to people in the UK.
These stories are transcripts from the original sources (indicated on each page) and appear as published. They have not been edited by the MS Trust and views expressed are those of the authors or originating journal. The MS Trust does not endorse their content nor any claims made in them.
Stories are held on these pages for three months.
If you have any comment on the range or type of stories collected here, please contact the MS Trust.
Recent news stories
Scientists use noses to help disabled write, surf, move
29 July 2010
Severely disabled people may soon be able to use their noses to write, drive a wheelchair or surf the Internet, thanks to a device developed and tested by doctors in Israel.
New benefits system forces three-quarters of claimants back to work
28 July 2010
A controversial new system for assessing whether the sick and disabled are capable of working has seen more than three-quarters of benefit claimants either told to get a job or abandoning their claim.
The Duchess of Cornwall joins the Red Wheelies as honourary member
28 July 2010
NEXT time the Red Wheelies mobility scooter display team line up for a performance, it might be worth checking their faces carefully.
MS patient's plea for treatment
28 July 2010
ILFRACOMBE MS sufferer Jayne Morrow and husband Dave are hoping a pioneering new treatment will help ease her condition.
Dealing with revolts by members, incorporation and payment of trustees
27 July 2010
Tony Kennan, chair of the MS Society, tells Andy Ricketts you have to meet the challenges head-on
Anti-closure protesters set to target York Multiple Scleroris Society's AGM
27 July 2010
PROTESTS against the threat of closure for a York respite care centre are set to be made at the Multiple Scleroris Society's annual general meeting.
Labour urges debate into future of MS respite home
27 July 2010
Labour is pressing for a debate in the Scottish Parliament on the future of Leuchie House, the respite home for multiple sclerosis sufferers in East Lothian.
Church supports stem cell project
26 July 2010
Research being carried out in Bristol into the medical use of adult stem cells to help multiple sclerosis sufferers is being funded by the Catholic Church.
University conference to study brain cells
22 July 2010
Neuro-scientists from around the world are gathering at the University of Portsmouth this week.
Scottish vitamin D summit captures international attention
21 July 2010
Shine on Scotland campaigners and the MS Society Scotland held productive talks with the Scottish Government yesterday as planning continues for the Scottish Summit on Vitamin D and MS which will take place in Glasgow in September.
First step to sustainable care and support system
20 July 2010
The first step towards creating a sustainable care and support system for all adults, that puts individuals and their families at its heart, was unveiled today by Health Secretary Andrew Lansley.
O2 Health launches Wii fit-style trials
20 July 2010
NHS East Berkshire is to trial technology to allow patients to carry out rehabilitation exercises at home without needing to see a physiotherapist, as part of the launch of O2 Health.
NHS to collect raft of data on quality of care: Department of Health
20 July 2010
The NHS is to be ordered to collect a raft of new measures on the quality of patient care just as the new Coalition government abolishes targets, it has been announced.
Specialists explore options for treating natalizumab-associated PML
20 July 2010
A new case report suggests that natalizumab-associated progressive multifocal leukoencephalopathy (PML) may be successfully treated in a patient with multiple sclerosis, if caught early.
New online service to improve the information given to patients
20 July 2010
A new on-line Information Prescriptions Service is now available to help ensure that patients get the information they need, when they need it most.
Liberating the NHS: Improving outcomes for patients
19 July 2010
Detailed proposals for how the NHS will improve healthcare outcomes for patients and judge its success were set out in a public consultation by the Department of Health today.
Blow for MS sufferers as plan for centre fails
19 July 2010
Plans for a multiple sclerosis centre in Bradley Stoke [Bristol] have stalled after planners turned down an application for access to the site.
Of bugs and brains: Researchers discover that gut bacteria affect multiple sclerosis
19 July 2010
Biologists at the California Institute of Technology have demonstrated a connection between multiple sclerosis (MS) - an autoimmune disorder that affects the brain and spinal cord - and gut bacteria.
New guide to UN convention on the rights of persons with disabilities
19 July 2010
Commission seeks assurance from Government that the treaty will be fully implemented.
NHS 'should focus on outcome goals'
19 July 2010
The Government has set out how NHS standards are likely to be measured in future, with a focus on how well treatments and care are working for patients.
British researchers create world's first robotic legs
16 July 2010
Two Britons living in New Zealand have built a pair of bionic legs that allow paraplegics to walk again.
Three more PML brain infections, one more death in Tysabri users
15 July 2010
Biogen Idec Inc. disclosed three more cases of a rare brain infection in multiple sclerosis patients on Tysabri, which it sells with Elan Corp., bringing the total number of cases to 58 as of July 2.
Thousands back Leuchie
15 July 2010
The bid to save Leuchie House is gathering momentum as close to 3,000 people have pledged their support to keep the MS facility open.
Millions of books get digitized for the disabled
14 July 2010
For those who are blind, dyslexic or have diseases like multiple sclerosis and have difficulty turning book pages, reading the latest best seller just got easier.
Cannabinoids for the management of neuropathic pain: review of clinical effectiveness
14 July 2010
The Canadian Agency for Drugs and Technologies in Health (CADTH) has published a review of clinical and cost effectiveness on the use of cannabinoids for the management of neuropathic pain.
Health white paper: the details
13 July 2010
A radical new vision for the health service has been laid out by ministers effecting all areas of the NHS and healthcare.
Another day, another accent for NZ woman
13 July 2010
An Invercargill woman believes she has foreign accent syndrome - a rare disorder which has changed her New Zealand accent to a British one.
Clinical trials of parasitic worms to treat MS, related to the "hygiene hypothesis"
13 July 2010
At least two small clinical trials are currently underway - one supported with funding from the National MS Society - to test the idea that infection with intestinal parasites may reduce immune attacks in MS.
NHS to adopt zero tolerance approach to pressure ulcers
13 July 2010
Pressure ulcers can cause serious pain and severe harm to patients and cost the NHS billions of pounds each year to treat. Yet in the majority of cases they can be prevented if simple measures were followed.
Health white paper - what nurses need to know
13 July 2010
Health secretary Andrew Lansley has set out his blueprint for the future of the NHS in a white paper.
Can a controversial new treatment for multiple sclerosis offer relief?
12 July 2010
A new treatment is giving hope to MS sufferers such as Mark Walker. So why can't he get it in Britain? Liz Hunt reports.
NHS shake-up grants new powers to doctors and patients
12 July 2010
Patients and family doctors are to be given a central role in the NHS as the Government unveiled plans for the biggest NHS shake-up in decades.
Equity and excellence: Liberating the NHS
12 July 2010
Secretary of State for Health Andrew Lansley today set out the Government's ambitious plans to reform the NHS during this Parliament and for the long-term.
Sleep disorders common in multiple sclerosis
09 July 2010
Sleep disorders are highly prevalent in patients with multiple sclerosis (MS) and may exacerbate fatigue associated with the condition, according to a study presented here at the Consortium of Multiple Sclerosis Centers 24th Annual Conference and the Third Joint Meeting of Americas Committee for Treatment and Research in Multiple Sclerosis.
Hippocampal atrophy, high cortisol found in depressed MS patients
09 July 2010
Multiple sclerosis (MS) patients have a lifetime depression risk as high as 50%, and new imaging studies suggest that the cause may be both physical and psychological.
USF receives patent for technology to improve treatment for neurodegenerative diseases
08 July 2010
Umbilical cord blood cells and mannitol pass the blood-brain barrier.
MS patient takes up drag racing after drug changes life
07 July 2010
A multiple sclerosis sufferer told today how her life was turned around after a London hospital gave her a "miracle" drug.
New website about work and disability
07 July 2010
The UK MS Society has worked with other organisations to create Worklife, a website for people with long-term health conditions who want to stay in work, for their employers and for health professionals.
Natalizumab improves language processing in patients with multiple sclerosis
07 July 2010
Treatment with natalizumab (Tysabri) leads to improved language processing and retrieval of newly learned verbal material in patients with multiple sclerosis (MS), according to research presented here at the Consortium of Multiple Sclerosis Centers 24th Annual Conference and the Third Joint Meeting of Americas Committee for Treatment and Research in Multiple Sclerosis.
Interim results of ofatumumab phase II study in multiple sclerosis
06 July 2010
Genmab announces interim results from a Phase II study of ofatumumab in RRMS.
UB neurosurgeons experimenting with MS procedures
06 July 2010
Researchers at the University at Buffalo Neurosurgery Department began testing a new procedure last week for treating multiple sclerosis.
Movement therapies may reduce chronic pain
05 July 2010
Yoga, tai chi, qigong and other exercises appear to help people suffering from cancer, arthritis, fybromyalgia, multiple sclerosis and other problems.
Don't ask Dr Google: How the worryingly poor online medical advice could affect your health
04 July 2010
Soaring numbers of patients who consult 'Dr Google' about their injuries may be getting diagnoses which are wrong or incomplete, a new report revealed today.
New disability benefits system 'needs radical change or 2.5m incapacity claimants will remain unemployed'
03 July 2010
The architect of a new benefits system has warned radical changes must be made to avert serious problems for vulnerable people.
Pregnant women 'must take vitamin D supplements'
03 July 2010
Pregnant women in the UK should be told to routinely take vitamin D supplements, researchers say.
Clarification re media comment on Sativex
02 July 2010
In response to a story in a regional UK media outlet yesterday, GW wishes to make the following clarification:
Simple eye test measures damage from multiple sclerosis
01 July 2010
A quick, painless eye measurement shows promise as a way to diagnose multiple sclerosis in its very early stages, and to track the effectiveness of treatments, researchers from University of Texas Southwestern Medical Center have found in a multicentre study.
Cancer drug to treat arthritis, multiple sclerosis
01 July 2010
A drug already available for treating cancer could also help in the treatment of a range of inflammatory diseases like arthritis, multiple sclerosis, inflammatory bowel disease, and lupus, say scientists.
MS sufferers in the south refused cannabis drug
01 July 2010
Doctors across southern England have been told not to prescribe a new cannabis-based drug developed for people with multiple sclerosis (MS).
Brain atrophy responsible for depression in people battling multiple sclerosis
01 July 2010
Study finds hippocampus is affected by imbalance in neuroendocrine system.
Clinical trial testing new multiple sclerosis treatment to launch in Buffalo
29 June 2010
Researchers at the University at Buffalo, led by the Department of Neurosurgery, will embark on a landmark prospective randomized double-blinded study to test the safety and efficacy of interventional endovascular therapy - dubbed "liberation treatment" - on MS symptoms and progression.
Patients free to buy their care with NHS money
29 June 2010
Patients are set to be given money by the NHS to spend on healthcare services of their choice.
More power to the patient
29 June 2010
Patients will be offered more choice and control over their healthcare with the launch of the first direct payment scheme, Care Services Minister Paul Burstow announced today.
Welfare crackdown begins with drive to reduce incapacity benefit claims
28 June 2010
Coalition's plans include taking people off higher rate of benefits if tests reveal they are fit to do some work.
MS patients create own informal experiment, going in droves for unproven therapy
28 June 2010
Scores, even hundreds of people with multiple sclerosis have in the last half-year or so undergone a procedure many hope will cure or at least improve their disease symptoms.
Sixty-two year old chemotherapy treatment shows promising results on progressive multiple sclerosis patients
28 June 2010
Study shows ITMTX may have beneficial role in progressive forms of MS.
Margarine, processed meats and other foods can increase the risk of multiple sclerosis
27 June 2010
Increased production of certain types of industrially produced foods - specifically of margarine, processed meat and sausage, jam and marmalade, chocolate and chocolate confectionary, sugar confectionary and beer - correlates statistically with an increased incidence of multiple sclerosis (MS).
Protesters hold Woodlands respite care centre demo
25 June 2010
A demonstration has been held by protesters angry at the possible closure of the area's only respite centre for people with multiple sclerosis.
MS sufferer appeals for help as council ditch her stairlift pleas
25 June 2010
A desperate mum suffering from agonising multiple sclerosis this week claimed East Ayrshire Council is refusing to carry out essential improvements at her house because social workers are convinced her condition will only get worse.
Anger at possible Helen Ley closure
24 June 2010
Outrage has been expressed over the threat of closure to Helen Ley Care Centre in Leamington.
Psychological therapies offered across the NHS
23 June 2010
Psychological therapies will continue to be rolled out across the NHS in the coming year Health Secretary Andrew Lansley announced today.
MS treatment in final clinical trial stage
23 June 2010
Abbott Laboratories and its Massachusetts biotech partner have launched a final-stage clinical trial of their experimental treatment for multiple sclerosis.
MS drug's epic journey from folklore to lab
22 June 2010
Research into ancient Chinese fungus that propagates inside insects yields potential relief for multiple sclerosis.
Overheating a multiple sclerosis threat
22 June 2010
Summer heat can cause the recurrence of MS symptoms for people with multiple sclerosis, a US neurologist warns.
Direct coping and planning results in less multiple sclerosis flare-ups than dealing with stress on an emotional level
22 June 2010
Multiple sclerosis patients who directly confronted the stress of the Second Lebanon War suffered fewer attacks than those who chose to cope with the situation by focusing on feelings.
Cannabis spray for MS: Controversial medicine that relieves pain gets go-ahead
22 June 2010
The first cannabis-based medicine has been given the go-ahead for use in Britain by MS sufferers.
ENS 2010: Multiple sclerosis, migraine and dementia: new insights from neuroimaging
22 June 2010
Innovative imaging techniques such as functional MRI or diffusion tensor imaging occupy an important place in modern neurology today.
Campaign to save MS Society respite centres
22 June 2010
Petition calls for reversal of decision to close four care homes.
MS sufferers welcome first licensed cannabis-based drug
22 June 2010
The first licensed medical drug containing whole cannabis plant extracts has been launched to treat symptoms of multiple sclerosis (MS).
Cannabis-based prescription drug approved to treat MS
21 June 2010
A cannabis-based drug which can be taken by multiple sclerosis (MS) sufferers has been approved for use in the UK.
Cannabis-derived drug is launched in UK
21 June 2010
A drug manufactured from cannabis went on sale in the UK Monday as a treatment for symptoms of multiple sclerosis.
Latest MS drug contains cannabis
21 June 2010
The first licensed medical drug containing whole cannabis plant extracts has been launched to treat symptoms of multiple sclerosis (MS).
GW Pharmaceuticals on a high after multiple sclerosis medicine Sativex wins approval
20 June 2010
Even if you were to track down the location and break into the computer-controlled greenhouse, the cannabis plants you would find at GW Pharmaceuticals' top-secret farm would be unlikely to give you the high you were hoping for.
MS sufferer's 'despair' at centre closure
19 June 2010
A woman with severe multiple sclerosis said closing the Helen Ley Care Centre will be a "death sentence for many".
Minister recognises carers' contribution
18 June 2010
Care services minister Paul Burstow has spoken of the outstanding contribution that carers make to society during a visit to a Lambeth GP practice.
Why certain diseases go into remission during pregnancy
18 June 2010
During pregnancy, many women experience remission of autoimmune diseases like multiple sclerosis and uveitis. Now, scientists have described a biological mechanism responsible for changes in the immune system that helps to explain the remission.
Britain approves GW Pharma's cannabis drug Sativex
18 June 2010
GW Pharmaceuticals Plc's cannabis-derived medicine Sativex has been approved in Britain for treating spasticity in patients with multiple sclerosis, in a landmark decision for the small drugmaker.
Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in MS
18 June 2010
A panel of experts met in June 2009 to review and discuss available data on neutralising antibodies to interferon-beta therapy (NAbs) and their practical consequences for the treatment of patients with multiple sclerosis (MS).
Call to Prime Minister David Cameron over Woodlands Respite Care Home closure
18 June 2010
A direct appeal could be made to new Prime Minister David Cameron to try to save a threatened "lifeline" respite centre in York.
Biogen reports six new PML cases with Tysabri
17 June 2010
Six more patients taking Biogen Idec Inc's multiple sclerosis drug Tysabri have developed a potentially deadly brain infection known as PML, the company said.
Stem cell therapy 'damage' seen in kidney disease case
17 June 2010
A new complication has been seen in a patient with kidney disease who received stem cell therapy, scientists have warned.
New theory on CCSVI and MS needs further study, experts say
17 June 2010
A controversial new theory suggests reduced blood flow in the azygous and internal jugular veins may be associated with MS, possibly by causing an iron overload in the brain and spinal cord.
Test could detect MS nine years in advance
16 June 2010
A simple blood test that can predict multiple sclerosis up to nine years before symptoms appear is being developed by scientists.
Labour leader in bid to save Lothians MS respite centre
16 June 2010
Scottish Labour leader Iain Gray is seeking an urgent meeting with health secretary Nicola Sturgeon in a bid to save Scotland's only respite home for people with multiple sclerosis.
Getting on with life with multiple sclerosis
16 June 2010
Looking back now, Carol Galvin said there were pointers that something wasn't quite right back in 2005.
Anger over closure of Helen Ley Care Centre for MS patients
16 June 2010
A care centre for Coventry and Warwickshire people with severe multiple sclerosis is to be closed.
Carers require a bit of looking after too
15 June 2010
Caring for a relative is a job like no other. For a start most people don't recognise it as a real job in itself, it's just something you willingly do for a loved one, no matter the impact it has on your life.
Enrollment of first patient in phase II BG-12 combination trial in multiple sclerosis
15 June 2010
EXPLORE trial to evaluate oral BG-12 as combination therapy for patients who continue to experience disease progression despite ongoing treatment
Start opening veins for MS patients, MDs say
15 June 2010
People with multiple sclerosis should be able to have surgery on blocked neck veins as part of a clinical trial, says the Italian doctor who pioneered what has become known as the liberation therapy.
Doubts over vein blockages in people with MS
14 June 2010
Serious doubts have been cast over whether a vein disorder, purported to cause MS and which was uncovered last year, actually exists.
Isolation takes toll on carers
14 June 2010
Nearly three-quarters of people in the East of England looking after an ill, frail or disabled loved one do not have a life outside of caring, according to research.
Carers 'get no respite from role'
14 June 2010
Eighty per cent of people in Northern Ireland looking after an ill, frail or disabled loved one do not have a life outside of their caring role, new research has suggested.
Study adds fuel to debate over MS and blocked veins
14 June 2010
A study published online will add to the debate raging among the MS patient and research community. The paper, published in the Annals of Neurology, says researchers found no evidence that blockages in veins play a significant role in MS.
Active mind may protect MS patients
14 June 2010
Intellectual enrichment helped preserve memory and learning in multiple sclerosis patients, study says.
Pre-empting multiple sclerosis
13 June 2010
A breakthrough finding from Israel may lead to earlier diagnosis, more effective intervention, and perhaps even a cure for the autoimmune disease multiple sclerosis.
Virus infection may trigger unusual immune cells to attack nerves in multiple sclerosis
11 June 2010
A virus infection can incite the body to attack its own nerve tissue by activating unusual, disease-fighting cells with receptors for both viral and nerve proteins.
Are stem cell tourists being swindled?
11 June 2010
Maybe, maybe not. According to the July edition of the publication Popular Science and its online companion site PopSci.com, desperate US patients are headed offshore for experimental stem cell therapies, referred to as stem cell tourism.
Zivadinov's update on chronic cerebrospinal venous insufficiency (CCSVI) in multiple sclerosis
11 June 2010
Robert Zivadinov, MD, PhD provides a thoughtful update on the current status of chronic cerebrospinal venous insufficiency (CCSVI) research in multiple sclerosis.
Natalizumab an alternative for those in whom other MS treatments have failed
11 June 2010
A new study suggests that patients with relapsing-remitting multiple sclerosis (RRMS) in whom previous treatment regimens have failed remain stable or show improvement when switched to treatment with natalizumab (Tysabri).
Over $2.4 million committed to support seven initial CCSVI grants to determine the role of CCSVI (venous insufficiency) in MS disease process
11 June 2010
Over $2.4 million has been committed by the National MS Society (USA) and the MS Society of Canada to support seven new research projects focusing on the role of CCSVI (chronic cerebrospinal venous insufficiency) in MS.
FDA panel endorses first oral drug for multiple sclerosis [USA]
10 June 2010
But concerns about side effects led experts to vote for post-market study of lower-dose pill.
MS Society to give up respite sites
10 June 2010
Three respite care centres in England for people with multiple sclerosis will no longer be run by the MS Society under plans by the charity.
MS respite care centre to close
10 June 2010
Scotland's only respite care centre for people with multiple sclerosis is to close later this year.
FDA panel: Novartis sclerosis drug safe, effective [USA]
10 June 2010
Federal health experts [in the USA] said Thursday a first-of-a-kind multiple sclerosis drug from Novartis is safe and effective for controlling tremors, concentration problems and other symptoms of the debilitating disease.
Vitamin D exposure in childhood linked to age at onset of MS
10 June 2010
Levels of childhood sun exposure and the presence or absence of cod liver oil supplements predict age at onset of multiple sclerosis (MS), a new study suggests.
Vitamin D linked to poor learning performance in patients with MS
09 June 2010
A new study shows that serum vitamin D deficiency is associated with poor learning performance among patients with multiple sclerosis (MS).
Merck seeking approval for MS pill
08 June 2010
The battle to win US approval for the first multiple sclerosis (MS) pill has been stepped up after German firm Merck resubmitted a request for regulatory approval for its cladribine drug.
FDA staffers express safety concerns over Novartis MS pill
08 June 2010
Documents released ahead of a US regulatory panel meeting on Thursday suggest that Novartis may have a tricky time in getting a recommendation for approval of its eagerly-anticipated oral multiple sclerosis treatment Gilenia.
Cancer drug shuts down MS activity
08 June 2010
Cladribine, an oral drug already marketed for hematologic cancers under the trade name Leustatin, was superior to placebo in reducing progression and other signs of MS disease activity, researchers here reported [CMSC-ACTRIMS].
Physical therapy improves urinary symptoms in patients with multiple sclerosis
08 June 2010
A physical therapy regimen improves both urinary incontinence and urinary retention in patients with multiple sclerosis (MS), according to a study presented here at the Consortium of Multiple Sclerosis Centers 24th Annual Conference and the Third Joint Meeting of Americas Committee for Treatment and Research in Multiple Sclerosis.
Cyclic methylprednisolone doesn't add to interferon-beta treatment in relapsing-remitting MS
08 June 2010
Pulsed monthly methylprednisolone has no effect on disability progression in patients with relapsing-remitting multiple sclerosis (MS) who are being treated with interferon beta-1a, according to a double-blind controlled trial.
DTB editorial questions NICE neuropathic pain guideline recommending pregabalin
08 June 2010
This editorial in the Drug and Therapeutics Bulletin (DTB) questions the recommendation in the recent guideline on neuropathic pain from NICE that clinicians should "offer oral amitriptyline or pregabalin as first-line treatment."
Study supports long-term safety profile of Betaferon for multiple sclerosis over 16 years
08 June 2010
Results from the 16-year follow-up to the pivotal Betaferon (interferon-beta-1b) trial, published today in the journal Neurology, provide the longest and most complete patient follow-up data and support the long-term safety profile of Betaferon in multiple sclerosis (MS).
Simple eye test measures damage from multiple sclerosis
07 June 2010
A quick, painless eye measurement shows promise as a way to diagnose multiple sclerosis in its very early stages, and to track the effectiveness of treatments, researchers from UT Southwestern Medical Center have found in a multicenter study.
Protein lets brain repair damage from multiple sclerosis, other disorders
07 June 2010
A protein that helps build the brain in infants and children may aid efforts to restore damage from multiple sclerosis (MS) and other neurodegenerative diseases, researchers at Washington University School of Medicine in St. Louis have found.
Intermittent exercise helps multiple sclerosis patients
07 June 2010
Patients with multiple sclerosis (MS) are able to exercise longer when they take intermittent rest breaks, according to a new study presented here at the Consortium of Multiple Sclerosis Centers 24th Annual Conference and the Third Joint Meeting of Americas Committee for Treatment and Research in Multiple Sclerosis.
Postpartum steroid reduces relapses
07 June 2010
A single dose of methylprednisolone given to new mothers with multiple sclerosis immediately after delivery reduced the risk of relapse for up to three months, researchers found.
Fingolimod supports ADLs in MS
07 June 2010
Multiple sclerosis patients who took the oral investigational agent fingolimod were better able to maintain activities of daily living (ADLs) over a year than those treated with injected interferon beta-1A, according to a study presented here.
Content of OTC vitamin D low, unpredictable
07 June 2010
Multiple sclerosis (MS) patients taking over-the-counter (OTC) vitamin D aren't getting what they're paying for, or what their neurologists recommend, according to a study presented here.
Interferon adjunct reduces MS lesions
06 June 2010
The oral drug teriflunomide demonstrates short-term safety and reduces lesions in multiple sclerosis for up to one year when used in combination with interferon beta, according to a study presented here [CMSC-ACTRIMS meeting].
Urinary rehab effective in MS
05 June 2010
Individualized rehabilitation can improve urinary dysfunction in multiple sclerosis (MS) patients independent of disease duration or disability, according to a study presented here [CMSC-ACTRIMS meeting].
Low sunlight linked to MS onset age
04 June 2010
Age of onset of multiple sclerosis was more than two years earlier in patients who lived in northern latitudes - with reduced exposure to the sun in fall and winter - during childhood, researchers found.
MS drugs scheme "a costly failure" for the NHS
04 June 2010
The multiple sclerosis risk sharing scheme is "a costly failure" and should not be continued, according to researchers on bmj.com today.
NHS 'has wasted millions on MS drugs which did nothing to help patients'
04 June 2010
The NHS has wasted millions of pounds on MS drugs which did nothing to help patients, according to experts.
Safety fears hang over pioneering MS pill
04 June 2010
Gilenia leads US race as first multiple sclerosis pill - FDA panel to vote on drug June 10 - cancer and heart safety concerns expected to loom large.
Risk Sharing Scheme could not yield valid data after only two years follow up
04 June 2010
Prof Richard J Lilford, chair of the Scientific Advisory Committee for the Risk-sharing Scheme, responds to the recent criticism of the scheme.
UK scheme for MS drugs "a costly failure"
03 June 2010
Scheme launched in 2002 "wastes 50 million pounds a year" - Patients fared worse than expected, but scheme continues - Experts say drug firms were main beneficiaries.
Out of the shadows: our unknown immune system
02 June 2010
Deliberate infection with a blood-sucking worm seems an odd way to treat multiple sclerosis (MS).
Stem cell therapies for inflammatory brain diseases now possible
02 June 2010
A team of investigators from the University of California in Irvine (UCI) Sue & Bill Gross Stem Cell Research Center have recently made important strides in the field of using stem cells as therapies for mitigating the effects of injuries on the central nervous systems.
Study explains why healthy individuals don't get tremors
01 June 2010
Nerve signals in the spinal cord work to counteract signals from the brain that would otherwise lead to tremors in our movement, according to new research funded by the Wellcome Trust.
Immune system helps transplanted stem cells navigate in central nervous system
01 June 2010
By discovering how adult neural stem cells navigate to injury sites in the central nervous system, UC Irvine researchers have helped solve a puzzle in the creation of stem cell-based treatments: How do these cells know where to go?
Acupuncture's molecular effects pinned down: new insights spur effort to boost treatment's impact significantly
31 May 2010
Scientists have taken another important step toward understanding just how sticking needles into the body can ease pain.
Breakthrough in 'shakes' treatment could counteract disabling tremors
31 May 2010
Patients whose lives are made a misery by constant shakes and tremors, could soon be relieved of their symptoms.
People shouldn't think because I have MS I can't have a kid...
28 May 2010
After two successful pregnancies, Louise Flockhart has one simple piece of advice for other women with multiple sclerosis: "Go for it."
Enhanced FES system could aid MS sufferers
28 May 2010
The approximately 100,000 people in the UK who suffer with multiple sclerosis (MS) could benefit from improvements being made to a technology that eases mobility by electrically stimulating improperly functioning muscles and nerves.
When patients meet online, are there side effects?
28 May 2010
Could we cure diseases faster, or at least better control them, through crowd-sourcing?
Escitalopram provides symptom relief for patients with MS and MDD
28 May 2010
Treatment with escitalopram appears to be an effective therapy for patients who have multiple sclerosis (MS) and comorbid major depressive disorder (MDD), researchers suggested at the 2010 Annual Meeting of the American Psychiatric Association (APA).
Queen's Speech unveils new Health Bill and vision for NHS
27 May 2010
The Queen has outlined the new coalition government's plans for introducing a Health Bill that will cement its vision for a National Health Service run by clinicians and free from political meddling.
MS fears at work incorrect, study finds
27 May 2010
After a decade with multiple sclerosis, Fiona Hall is all too familiar with the uncomfortable walk to the boss's office to talk about her disease.
Mobility scooter display team completes epic trek
27 May 2010
A team of multiple-sclerosis sufferers has completed their 150-mile mobility scooter-powered trek from Winchester to Canterbury.
Gayle Bloomfield's hope for Paralympics dressage glory
27 May 2010
A rider who vowed she would never get back in the saddle after becoming crippled by multiple sclerosis is now on the road to Paralympic glory.
Free prescription plans 'on hold'
27 May 2010
Proposals to give free prescriptions to people in England with long-term conditions have been put on hold due to financial pressures on the NHS.
Prescription charges review
27 May 2010
Implementing exemption from prescription charges for people with long term conditions.
Multiple sclerosis: World MS Day
26 May 2010
To mark the awareness day, we talk to one of the UK's experts in the field of multiple sclerosis about current and future treatments, MS research and problems in the workplace for people with MS.
First major survey of multiple sclerosis (MS) nurses highlights significant disparities in MS nursing across Europe
26 May 2010
The findings from MS-NEED (Multiple Sclerosis-Nurse Empowering EDucation): European survey highlights the need to define and benchmark healthcare provision in MS across Europe.
MSIF statement on CCSVI
26 May 2010
MSIF [Multiple Sclerosis International Federation] has published a statement on Chronic Cerebrospinal Venous Insufficiency (CCSVI), based on consultation with a wide range of contributors.
New disabled benefit system 'unfit'
26 May 2010
One of the architects of a new benefit system for disabled people has urged the Government to delay rolling it out after evidence that medical tests are wrongly finding thousands of people fit for work.
Assessments under new benefits system investigated
26 May 2010
A BBC Scotland investigation finds that tens of thousands of claimants who are genuinely sick or disabled may have been refused the new Employment Support Allowance.
Has residential respite care had its day?
26 May 2010
The MS Society is about to decide whether to close all its respite care homes and offer more personalised support to its users. The outcome could have repercussions for other disability charities.
Your story, your voice, your achievements, your ideas... This is about life, real life, Real MS
26 May 2010
Global campaign to raise awareness of MS across the world.
Phase III Trial of MS antibody daclizumab starts
25 May 2010
Biogen Idec Inc and Abbott kicked off a Phase III trial comparing their anti-IL-2 antibody daclizumab to Biogen's Avonex (interferon beta-1a) in relapsing-remitting multiple sclerosis.
Extension of US regulatory priority review period for FTY720
25 May 2010
US Food and Drug Administration (FDA) extends priority review period by three months to September 2010, in line with previously announced expectations
Vitamin D: hope on the horizon for MS prevention?
25 May 2010
Vitamin D deficiency might be an important modifiable risk factor for MS. This raises the question of whether population-wide supplementation programmes might be a reasonable prevention strategy.
Survey reveals economic toll of MS
25 May 2010
Nearly half of MS patients stop working within 3 years of diagnosis
Slow multiple sclerosis progression with cannabinoids
24 May 2010
A $1.5 million National Institutes of Health grant will help Temple University [in Philadelphia] researchers study more effective ways to treat multiple sclerosis (MS).
Regenerative medicine: the body is expert at repairing itself
24 May 2010
James Le Fanu's Doctor's Diary: The bone marrow is a particularly versatile source of stem cells, which could help patients with multiple sclerosis.
When helper cells aren't helpful
24 May 2010
Current research suggests that T helper-type 1 (Th1) cells, previously thought to mediate autoimmunity, may actual inhibit the development of experimental immune encephalomyelitis (EAE), a mouse model of multiple sclerosis (MS), by suppressing Th17 cells.
A new prescription: parasite eggs
24 May 2010
Scientists test whether whipworms can fight autoimmune disorders.
Walter Williams of the O'Jays opens up about long battle with multiple sclerosis
23 May 2010
It started with a numb big toe.
To hell and back
23 May 2010
Maria Blackburn was with her two-year-old son when she overheard someone across the road pass critical comments about her for being drunk and in the company of a young child.
Gut instinct: the miracle of the parasitic hookworm
23 May 2010
When Jasper Lawrence heard of a radical cure for his allergies, he decided to give it a go: he went to Africa and infected himself with a blood-sucking parasite. Now he's cured, and he believes hookworm can help people with asthma, diabetes and MS. Only one problem - he's on the run from the law.
The NHS must put patients first
21 May 2010
Bureaucracy and a top-down approach have undermined the health service, writes Andrew Lansley. Patients and clinicians must be put in control.
Pledge to overhaul social care
21 May 2010
Ministers today pledged to urgently overhaul Britain's "unsustainable" social care system and tackle a growing problem which the Labour government did little to address during its time in office.
Sativex deemed approvable by regulators in UK/Spain
20 May 2010
It was good news for GW Pharmaceuticals and Spanish partner Almirall this morning after regulators in the UK and Spain agreed that, under the decentralisation procedure, Sativex is approvable in Europe.
'End wheelchair lottery' say AMs
20 May 2010
People are having to wait much longer to get wheelchairs in north Wales compared with those in the south, an assembly committee report says.
Dunham back in style
20 May 2010
Broad Hinton based British Paralympian Anne Dunham has returned to the competition arena in style, after a two-year break from the international scene following major heart surgery.
Male continence problems focus of new NICE guidance
20 May 2010
NICE has set out very specific guidelines for dealing with male continence problems.
Safety concerns bring an end to Biogen, Roche RA program
20 May 2010
A Phase II study of ocrelizumab is ongoing in patients with relapsing remitting multiple sclerosis.
Multiple hopes for multiple sclerosis
20 May 2010
Anette Hansson, is one of the tens of thousands that fall prey to MS across Europe, she describes the onset of the disease.
Cholesterol drug side effects need watching: study
20 May 2010
People using cholesterol-lowering statins have a higher risks of liver dysfunction, kidney failure, muscle weakness and cataracts and such side effects of the drug should be closely tracked, doctors said on Friday.
Doctor approaches healing from a patient's perspective
19 May 2010
Elizabeth Morrison knows what it's like when the doctor becomes the patient - because that's exactly what happened to her.
New clinical trial of investigational multiple sclerosis treatment
18 May 2010
Apitope, the European biotech company developing therapeutic peptides to treat autoimmune and allergic diseases, today announced the start of its second Phase I clinical trial of ATX-MS-1467, in patients with multiple sclerosis (MS).
Radical treatment gives MS patient his life back
18 May 2010
A new stem cell treatment has saved the life of a young Australian with multiple sclerosis, but MS Australia still warns the procedure is "experimental".
Drug-resistant urinary infections
18 May 2010
Urinary tract infections may become resistant to antibiotics through the "overuse of antibiotics in the farming industry", BBC News has said.
Urinary tract infections 'resistant to antibiotics'
17 May 2010
Urinary tract infections are becoming increasingly hard to treat because of emerging resistance to current antibiotic drugs, experts warn.
Is Italian doctor's MS treatment more hype than help?
15 May 2010
For the past six months, the media have been abuzz with stories touting the overwhelming success of a radical, new procedure to treat multiple sclerosis.
Total PML cases at 49, deaths at 11 as of May 6
14 May 2010
Biogen Idec Inc disclosed three more cases of a rare brain infection in multiple sclerosis patients on Tysabri, which it sells with Elan Corp, bringing the total number of cases to 49 as of May 6.
NHS cuts may be deeper than expected, warns Lansley
13 May 2010
Andrew Lansley, the new health secretary, says there is a case for 'efficiency savings' of more than 3%.
More power to patients
13 May 2010
As long-term health conditions affect an increasing proportion of the UK population, the cost of care provision is a growing concern. Mark Gould reports on current barriers to improvement and possible solutions.
MS cases on the rise in Hispanic community [in the USA]
13 May 2010
About 400,000 Americans suffer from the vision and mobility robbing condition multiple sclerosis. While the disease is more likely to afflict Caucasians, it's showing up more and more in minorities.
Meta-analysis: Intravesical botulinum toxin for idiopathic overactive bladder
13 May 2010
According to the results of a meta-analysis reported in the Journal of Urology, intravesical botulinum toxin improves the symptoms of overactive bladder (OAB), but is associated with a significant risk of urinary retention.
Access row threatens Bradley Stoke MS centre
13 May 2010
A row has broken-out over an access route to a planned multiple sclerosis (MS) therapy centre in Gloucestershire.
EU agency prepares to assess first stem cell drug
12 May 2010
The first regenerative medicine based on stem cells could be filed for approval in Europe later this year, bringing the groundbreaking medical technology a step closer to reality.
European and international experts discuss the way forward in stem-cell research and development
12 May 2010
The European Medicines Agency (EMA) assembled for the first time European and international experts from academia, regulatory authorities (from Europe, Japan and the United States) and pharmaceutical industry, in a workshop on 10 May 2010, to review opportunities and difficulties in developing stem cell-based therapies and to discuss regulatory challenges.
Ward duties put specialist nurse roles at risk
11 May 2010
Trusts that send clinical nurse specialists back to the wards could be putting the future of the clinical nurse specialist role at risk, Nursing Times had been told.
Eight million people live with chronic pain
11 May 2010
But with a combination of drugs, surgery, physio and psychological treatment, it can be beaten.
Many pregnant women not getting enough vitamin D
11 May 2010
Prenatal vitamins help, but are not enough for everyone.
Stem cells use GPS to generate proper nerve cells
11 May 2010
An unknown function that regulates how stem cells produce different types of cells in different parts of the nervous system has been discovered by Stefan Thor, professor of Developmental Biology, and graduate students Daniel Karlsson and Magnus Baumgardt, at Linköping University in Sweden.
Multiple sclerosis stem cell therapy guidelines launched
10 May 2010
On 6 May 2010, the journal Nature Reviews Neurology published a new report about the future of multiple sclerosis (MS). The guidelines focus on the use of stem cell therapy.
Researchers explore new ways to potentially reverse the damage caused by multiple sclerosis
10 May 2010
A National Institutes of Health grant will help University of Central Florida researchers explore new ways to potentially reverse the damage caused by multiple sclerosis and other neurological disorders.
Genetic variants tied to MS, study finds
09 May 2010
Variants of a gene called CBLB are associated with multiple sclerosis in humans, a new study finds.
Stem cell therapy for multiple sclerosis: trials and tribulations
08 May 2010
The first, small-scale clinical trials of stem cells as a treatment for multiple sclerosis (MS) have reportedly shown promising results.
Art teacher who suffers from multiple sclerosis fined for possessing half kilo of cannabis
07 May 2010
A multiple sclerosis sufferer found with almost half a kilo of cannabis has been fined £500.
Integrated community neurology service - first in the UK
06 May 2010
NHS Nottingham City has today launched the first fully integrated of its kind Community Neurology Service in the country to help patients with Long Term Neurological Conditions (LTNC) - these include Parkinson's, epilepsy and multiple sclerosis (MS).
MS stem cell therapy trialled
06 May 2010
Behind the Headlines
"A controversial trial using bone marrow stem cell therapy for MS patients has helped stabilise the disease," reported the Daily Mail.
Overactive bladder drugs differ on side effect severity
05 May 2010
The antimuscarinic drug solifenacin is associated with significantly fewer side effects than another drug in the same class, oxybutynin, according to Canadian researchers.
Study of bone marrow stem cells in MS shows promise
05 May 2010
A groundbreaking trial to test bone marrow stem cell therapy with a small group of patients with multiple sclerosis (MS) has been shown to have possible benefits for the treatment of the disease.
Stem cells raise hope for treatment for multiple sclerosis patients
05 May 2010
Thousands of MS sufferers could benefit from a revolutionary treatment that injects them with stem cells taken from their own bone marrow.
Important control mechanism behind autoimmune diseases discovered
05 May 2010
Researchers at the Swedish medical university Karolinska Institutet have discovered a new control mechanism in our immune system.
New website helps people remain in work
05 May 2010
A new website is being launched by a group of disability charities, employment organisations, healthcare professionals and the Department of Work and Pensions (DWP) to help people with long-term fluctuating health conditions remain in work.
Innate Therapeutics receives funding for clinical trial of progressive multiple sclerosis therapeutic
05 May 2010
Innate Therapeutics today announced funding support from Fast Forward, LLC, a not-for-profit organization established by the US National Multiple Sclerosis Society and EMD Serono, an affiliate of Merck KGaA, Darmstadt, Germany.
Book tackles serious issue in entertaining way
04 May 2010
When his pregnant wife was diagnosed with multiple sclerosis at the age of 24, Ian McMurdo believed she would die.
Canadian trials to examine 'liberation procedure' for multiple sclerosis
03 May 2010
Duncan Thornton is still getting used to enjoying the small things that most Canadians take for granted.
New treatment helps MS patients achieve 'long-lasting remission'
03 May 2010
Ottawa doctors, who claim a new medical technique can cause a "very long-lasting remission," are giving hope to multiple sclerosis patients.
Sun-shy mothers may raise MS risk in babies: study
30 April 2010
Children whose mothers had low exposure to sunlight during their first three months of pregnancy may have a higher risk of developing multiple sclerosis later in life, a study in Australia has found.
Babies born in summer 'more likely to develop multiple sclerosis'
30 April 2010
Babies born in the summer months have a higher risk of developing multiple sclerosis (MS) because their mothers do not get enough sun during pregnancy, a study says.
